Promega Corporation

Detecting UV Irradiation-Induced Apoptosis with the Caspase-Glo® 3/7 Assay

Share

  • Share
  • Print
  • Email
  • Download PDF

Abstract

Allergan is a global healthcare company devoted to neuromuscular, skin and eye care products and specialty pharmaceuticals. We are interested in compounds that inhibit the apoptotic effect of UV irradiation. Here we demonstrate an application of the Promega Caspase-Glo™ 3/7 Assay for high-throughput screening of anti-apoptotic compounds.

Promega Notes 85, 19–20.

Ronald Lai

Allergan
Publication Date: 2003

Download Article (410 KB)

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.